how to contact about point injection dot com Is this in your scope of practice? Point Injection Seminars Intro to Point Injection Therapy protocols for neurological or mental diseases musculo-skeletal protocols gastro-intestinal protocols respiratory protocols urogenital protocols pediatric protocols sensory protocols cardio protocols Protocols Index


Recent Advances in Point Injection

Efficacy and safety of acupoint injection therapy for allergic rhinitis: A protocol for systematic review and meta-analysis.

Medicine (Baltimore). 2020 Oct 16;99(42):e22737

Authors: Chen Z, Xing S, Huang Y, Zeng Q, Xu D, He Q, Qin H, Luo X, Li R

BACKGROUND: Allergic rhinitis (AR), characterized by nasal itching, sneezing, and congestion, is a common disorder of nose. In the United States, AR affects 10% to 20% of adults. The negative impact of the high prevalence of AR has caused a great economic burdens worldwide. Modern Western Medicine mainly treats AR with antihistamine drugs, glucocorticoids, allergic immunotherapy (AIT), but it seriously affects patients compliance because of its long course of treatment, high medical costs and side effect. And now, as an important mean of treating AR, acupoint injection has been widely used in clinics, and has achieved significant efficacy.
METHODS AND ANALYSIS: The following databases will be searched for relevant information before July 2020: PubMed, Embase, Cochrane Library, Web of Science, and CNKI.
MAJOR RESULTS: scores of Rhinitis Quality of Life (RQLQ), Rhinitis Total Symptom Scores (RTSS). Secondary results: levels of antigen-specific serum immunoglobulin E (IgE), total effective rate, adverse event. Data will be collected independently by 2 researchers, and the risk of bias in meta-analysis will be evaluated according to "Cochrane Handbook for Systematic Reviews of Interventions". All data analysis will be conducted using Review Manager V.5.3. and Stata V.12.0.
RESULTS: The curative effect and safety of acupoint injection treatment for AR patients will be evaluated systematically.
CONCLUSION: The systematic review of this study will summarize the currently published evidence of acupoint injection treatment for AR to further guide its promotion and application.
ETHICS AND DISSEMINATION: The private information from individuals will not be published. This systematic review also will not involve endangering participant rights. Ethical approval is not required. The results may be published in a peer-reviewed journal or disseminated in relevant conferences.Open Science Framework (OSF) registration number:

PMID: 33080733 [PubMed - in process]

Efficacy and safety of acupoint injection therapy for allergic rhinitis: A protocol for systematic review and meta-analysis.


Point Injection Therapy Home | Point Injection Protocols
About | Contact
Point Injection Therapy Classes HealthCareWell Pharmacy
Site content compiled by Google author Dr. Al Stone
© 2002-2013
index.shtml was last modified Apr 25 2013.